| Beth Kreutzer, MD | |
|
1 Hospital Dr # Dc029.10, Columbia, MO 65212-1000 | |
| (573) 884-3233 | |
| Not Available |
| Full Name | Beth Kreutzer |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 1 Hospital Dr # Dc029.10, Columbia, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033789904 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 2021031126 (Missouri) | Primary |
| Entity Name | Southeastern Emergency Physicians Of Memphis Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437105277 PECOS PAC ID: 5395643209 Enrollment ID: O20060711000434 |
News Archive
Inhibitex, Inc. today announced its financial results for the third quarter ended September 30, 2011 and provided an update on several recent corporate developments, including top-line safety and antiviral data from the first cohort in its ongoing clinical trial designed to evaluate higher doses of INX-189, an oral nucleotide polymerase inhibitor, being developed to treat chronic infections caused by hepatitis C virus (HCV), administered as monotherapy or in combination with ribavirin for seven days.
Every state can now lay claim to the nanotechnology revolution. Data released today by the Project on Emerging Nanotechnologies (PEN) highlights more than 1,200 companies, universities, government laboratories, and other organizations across all 50 U.S. states and in the District of Columbia that are involved in nanotechnology research, development, and commercialization. This number is up 50 percent from the 800 organizations identified just two years ago.
The number of obese Americans is expected to increase to 113 million by the year 2022, making the U.S. the most overweight country in the world.
Stroke, a condition traditionally associated with old age, is increasingly affecting young and middle aged people, according to a major new analysis from the Global and Regional Burden of Stroke in 1990-2010 study, published in The Lancet.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it has received approval from Health Canada, the country's federal department responsible for helping Canadians maintain their health, to market the HeartWare Ventricular Assist System as a bridge to heart transplantation in patients with end-stage heart failure.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Beth Kreutzer, MD 1 Hospital Dr # Dc029.10, Columbia, MO 65212-1000 Ph: (573) 884-3233 | Beth Kreutzer, MD 1 Hospital Dr # Dc029.10, Columbia, MO 65212-1000 Ph: (573) 884-3233 |
News Archive
Inhibitex, Inc. today announced its financial results for the third quarter ended September 30, 2011 and provided an update on several recent corporate developments, including top-line safety and antiviral data from the first cohort in its ongoing clinical trial designed to evaluate higher doses of INX-189, an oral nucleotide polymerase inhibitor, being developed to treat chronic infections caused by hepatitis C virus (HCV), administered as monotherapy or in combination with ribavirin for seven days.
Every state can now lay claim to the nanotechnology revolution. Data released today by the Project on Emerging Nanotechnologies (PEN) highlights more than 1,200 companies, universities, government laboratories, and other organizations across all 50 U.S. states and in the District of Columbia that are involved in nanotechnology research, development, and commercialization. This number is up 50 percent from the 800 organizations identified just two years ago.
The number of obese Americans is expected to increase to 113 million by the year 2022, making the U.S. the most overweight country in the world.
Stroke, a condition traditionally associated with old age, is increasingly affecting young and middle aged people, according to a major new analysis from the Global and Regional Burden of Stroke in 1990-2010 study, published in The Lancet.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it has received approval from Health Canada, the country's federal department responsible for helping Canadians maintain their health, to market the HeartWare Ventricular Assist System as a bridge to heart transplantation in patients with end-stage heart failure.
› Verified 9 days ago
Rylee Shawn Duckworth, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-884-4400 Fax: 573-884-5994 | |
Dr. Michael Habhab, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr Emergency Medicine M562 Dc029.10, Columbia, MO 65212 Phone: 573-884-4400 | |
Michael Hauan, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1600 E Broadway, Columbia, MO 65201 Phone: 573-815-3573 Fax: 314-631-4491 | |
Derek G Hebert, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-882-6003 Fax: 573-884-5410 | |
Dr. Betsy Lynn Borsheski, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-882-8091 Fax: 573-884-1902 | |
Dylan Carroll, Emergency Medicine Medicare: Medicare Enrolled Practice Location: One Hospital Drive, Suite M562, Columbia, MO 65212 Phone: 573-884-3233 Fax: 573-884-5994 |